Clinical Trial Update: Study of Albumin to Reduce Inflammation Following Surgery [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating albumin to reduce inflammation after surgery was terminated. The study focused on systemic inflammatory response syndrome linked to c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Inflammatory Response Syndrome

Drugs mentioned

• Albumin

Snippet

Sponsor: Imperial College London | Conditions: Systemic Inflammatory Response Syndrome, Cardiopulmonary Bypass | Phase 2 | Status: TERMINATED